Loading...
Loading...
reported upbeat results for the fourth quarter.
The Woonsocket, Rhode Island-based company posted quarterly net earnings of $1.32 billion, or $1.14 per share, compared to $1.27 billion, or $1.05 per share, in the year-ago period. Excluding non-recurring items, the company's adjusted earnings came in at $1.21 per share.
Its revenue climbed 12.9% to $37.06 billion. However, analysts were expecting earnings of $1.20 per share on revenue of $36.1 billion.
Revenue in the Pharmacy Services Segment rose 21.7% to $23.9 billion in the quarter, while revenue in the Retail Pharmacy Segment gained 2.9% to $17.7 billion.
Same store sales gained 1.6%, while pharmacy same-store sales climbed 5.5%.
Operating profit rose 4.7% to $2.3 billion in the quarter.
During the quarter, CVS Health opened 50 new retail drugstores and closed 7 retail drugstores.
President and CEO Larry Merlo, stated, "By any measure, 2014 was a great year for our company. We delivered strong financial performance, with solid year-over-year growth in revenues, operating profit, earnings per share and cash flow. Our performance in the fourth quarter was no exception, with Adjusted EPS increasing 8.4%, coming in at the high end of our expectations. At the same time, we generated free cash flow for the full-year of $6.5 billion, exceeding our expectations."
CVS affirmed its adjusted earnings forecast of $1.06 to $1.09 per share for the first quarter and $5.05 to $5.19 per share for 2015.
CVS shares rose 1.85% to $101.40 in pre-market trading.
Loading...
Loading...
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Date | ticker | name | Actual EPS | EPS Surprise | Actual Rev | Rev Surprise |
---|
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in